
Opinion|Videos|January 23, 2025
Monitoring Patients With Iron Deficiency Anemia After Diagnosis
Panelists discuss how monitoring patients with iron deficiency anemia requires regular follow-up appointments to track laboratory values, assess symptom improvement (particularly fatigue), and evaluate treatment response while considering the impact of comorbid conditions, with adjustments to therapy made based on both objective markers and patient-reported outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How are patients with IDA monitored after they have been diagnosed, and what is your approach to follow-up appointments?
- How do you monitor for improvements in fatigue in IDA while factoring in other comorbidities?
Advertisement
Related to this article

CRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.

San Francisco experts say earlier IgA nephropathy and FSGS detection depends on primary care education and care coordinators.

The FDA has approved secukinumab for PMR after the REPLENISH trial showed doubled sustained remission and lower steroid use vs a steroid taper alone.

Earlier MASH fibrosis detection is more urgent now that treatments exist, and automating FIB-4 in EHRs could help primary care, says Rohit Loomba, MD.

In this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.

Neladalkib earned accelerated approval for previously treated ALK-positive NSCLC, with ORRs of 49% and 32%.
Advertisement
Advertisement
Trending on AJMC
1
Health Equity & Access Weekly Roundup: November 20, 2026
2
Four Ways to Boost Awareness, Access for COVID-19 PEP
3
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor
4
Caregiving Cuts Across Party Lines: Sen Andy Kim
5

